ENDOMETRIOSIS

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

52 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-05-23

Study Completion Date

2026-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Endometriosis is a frequent pathology with an estimated prevalence of 10% of women of childbearing age. There is no exact correspondence between the symptoms described by the patients and the severity of the lesions, which makes clinical diagnosis difficult. It therefore seems important to improve the complementary examinations available to make the diagnosis more precise and to better study the effectiveness of the treatments implemented. The clinical examination and per-surgical findings of patients with deep pelvic endometriosis show a clear decrease in the mobility of the pelvic organs in relation to each other, but few studies have looked at this mobility, which could however have an implication in explaining the pathophysiology of the disease and the symptomatology of the patients, as well as in the detection of lesions preoperatively. The persistence of hypo-mobility could also help to understand treatment failures.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

ENDOMED: Evaluation of the Evolution of Endometriosis Lesions on Imaging Under Medical Treatment

NCT05722314

Endometriosis Pelvic

UNKNOWN

Bladder Endometriosis: Evaluation in MRI of the Involvement of the Posterior Inferior Wall

NCT03906760

Endometrial Bladder Disease

COMPLETED

Preoperative Staging of Endometriosis With MRI

NCT01939535

Endometriosis

COMPLETED

Diffusion Endometriosis MRI to Detect and Quantify Symptomatic Neurological Impairment in Pelvic Endometriosis

NCT06908655

Endometriosis

NOT_YET_RECRUITING NA

Value of Advanced MRI Techniques in the Assessment of Endometriosis

NCT06481982

Endometriosis

WITHDRAWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Endometriosis Mobility Limitation Magnetic Resonance Imaging Diagnosis Pelvis Comparative Study

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients with pelvic endometriosis

Patients referred for suspected pelvic endometriosis, with pelvic endometriosis on initial MRI

Dynamic MRI Sequence

Intervention Type OTHER

Addition of a Dynamic MRI Sequence during the MRI examination performed in routine care

patients without pelvic endometriosis

Patients referred for suspected pelvic endometriosis but without endometriosis found on diagnostic MRI.

Dynamic MRI Sequence

Intervention Type OTHER

Addition of a Dynamic MRI Sequence during the MRI examination performed in routine care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dynamic MRI Sequence

Addition of a Dynamic MRI Sequence during the MRI examination performed in routine care

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient referred for suspected pelvic endometriosis requiring pelvic MRI
* Female, nulliparous,
* patient with signed written consent, patient with health insurance,
* patient willing to comply with all study procedures and duration

Exclusion Criteria

* BMI \> 35,
* history of hereditary collagen and elastic tissue disease,
* history of pelviperitonitis,
* history of major pelvic surgery,
* inability to receive informed information,
* inability to participate in the entire study,
* lack of social security coverage,
* refusal to sign consent

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No